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This special issue is dedicated to those lipid mediators
playing roles in skin inﬂammation, a topic in continuous
evolution, due to relevant ﬁndings connecting the alterations
of lipid metabolism occurring systemically and at the skin
level. Currently, one of the main hopes is to ﬁnd clinically
relevantbiomarkersofdiseasesusceptibilityandprogression.
It is also important to identify molecules with therapeutic
potential for the main inﬂammatory pathologies with signif-
icant socioeconomic impact involving the skin. Among these
psoriasis, atopic dermatitis, or diabetic skin ulcer, as well as
less severe dermatologic conditions like acne or premature
aging,seriouslyaﬀectpatientqualityoflifeandpsychological
scores.
The skin is indeed a very peculiar organ, displaying
biochemical and immunological features speciﬁc for a com-
partment continuously exposed to external and endogenous
stimuli. Skin lipids, with their unique biochemical com-
position, provide protection from environmental stressors
although the formation of bioactive compounds such as
4-hydroxynonenal, oxysterols, and oxidized phospholipids
can be a consequence of exposure to these stressors. These
compounds derived mainly from the oxidation of the skin
lipids are essential in the regulation of skin and mucosal
tissue inﬂammation, since they are able to trigger, sustain, or
terminate cutaneous inﬂammatory processes. Their function
in the modulation of ROS, RNS, cytokine, and chemokine
production and release, in DNA and protein oxidation,
in gene expression, in the regulation of antioxidant and
detoxifying enzymes, is under extensive investigation. Their
control may therefore well represent a feasible tool for
clinical interventions aiming at the correct modulation of
skin physiological functions for possible disease prevention.
In line with these concepts, the articles contributing to
this issue provide new information or review current status
of research on the etiological role of lipid molecules and
their metabolites in acute or chronic inﬂammatory states of
the skin compartment, induced by endogenous diseases or
environmental factors.
Innovative approaches like postgenomics and lipidomics
are presented in the work of D. Braconi et al., as powerful
tools waiting for more extensive application in a deeper
investigation on skin pathophysiological processes. Systemic
and topical lipid oxidation is a key mechanism involved in
chronic inﬂammatory skin diseases, among which psoriasis,
acne, atopic, and seborrheic dermatitis are the most com-
pelling examples, as presented by S. Pastore et al. and A.
Pietrzaketal.Moreextensively,thedysregulationofthestrict
homeostatic systems active in the skin to maintain the redox
balance and counteract abnormal oxidative stress in chronic
inﬂammatory skin diseases is widely analysed, with special
attentiontohowthishighlycontrolledmechanismisaﬀected
by therapeutic intervention.
Among skin lipids, the surface hydrolipidic ﬁlm has
been studied for a long time, due to the very peculiar
composition of the sebaceous lipids and their speciﬁc
contributiontoskinprotectionandisolation.TheworkbyC.
De Luca et al. presents an overview of the current literature
on the oxidation of squalene and of other degradable2 Mediators of Inﬂammation
components of human sebum and the functions that these
compounds play in mediating the eﬀects of UV light and
other environmental physical, chemical, and microbiological
stressors on the skin layers. In addition, the role of oxidative
stress in dermatological diseases such as psoriasis and atopic
dermatitis as a trigger for such pathologies and a possible
therapeutic tool is discussed in the work by S. Pastore et al.
and A. Pietrzak et al. The speciﬁc role of sebum-derived lipid
mediators in the aetiology of acne is updated by E. Camera
et al., focussing on the latest advances concerning their
possible interference with biochemical patterns of sebocyte
diﬀerentiation and sebogenesis.
Lipid modiﬁcations induced by resident and pathogenic
microbial ﬂora, aﬀecting inﬂammatory status of the skin,
also receive proper attention in the issue. Locally, a deﬁcit of
immune response possibly due to loss of speciﬁc subsets of
dendritic cells may result in sustained inﬂammatory events,
secondary to repeated skin infections, as in the case of
Darier’s Disease as reported by C. Miracco et al.
Finally, extensive space is devoted to possible clinical
intervention tools, based on chemical or physical principles
directed at the prevention and suppression of excessive lipid
oxidation. The toxicity of skin lipid reactive mediators is
addressed with particular attention to the active principles
for systemic and topical application (C. De Luca et al.),
aimed at the prevention not only of sunburn but also of
local and systemic immunological impairment, resulting
in increased risk of photo-carcinogenesis. On the other
side, skin lipid oxidation products seem to bear promising
implications as eﬀective agents for the phototherapy of skin
hyperproliferative states.
G e n o m i ca p p r o a c h e sa r ep r o p o s e db yJ .V .G r u b e re t
al. for the individuation of speciﬁc eﬀects of active natural
plant phenolics on genes implicated in the main skin
pathophysiological processes, in view of the recent appraisal
of plant extracts as inhibitors of skin lipoperoxidation
and proinﬂammatory cytokines release. Alternative physical
treatments are reviewed, including the use of therapeutically
active ozonated derivatives (V. Travagli et al.), delivered
through an unsaturated lipid vehicle generating reactive
mediators in situ,f o rm o r ee ﬃcient treatment of recurrent
skin infections resistant to topical antibiotics. The feasibility
of dietary supplementation in the control of skin inﬂam-
matory processes is well exempliﬁed in the work by N.-Y.
Park et al. where SKH1 mice fed with conjugated linoleic
acid showed an enhancement of the early stage of cutaneous
wound healing, as a result of the modulation of oxidative
stress and inﬂammatory response.
In addition, the possible deleterious eﬀects of nons-
teroidal anti-inﬂammatory drugs or selective cyclooxygen-
ase-2 inhibitors on the fragile balance of proinﬂammatory
mediators in the course of wound healing are summarized
by W.-H. Su et al., contributing to the search for new
therapeutic tools possibly proving less harmful to the local
skin cytokine environment.
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